Zinc homeostasis and immunosenescence

Journal of Trace Elements in Medicine and Biology

Volumn 29, Issue , 2015, Pages 24-30

  Maywald, Martina ^a   Rink, Lothar ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Immunobiology; Immunosenescence; Zinc

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ADAPTIVE IMMUNITY; AGING; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EXTRACELLULAR TRAP; HELPER CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSENESCENCE; INFLAMMAGING; INNATE IMMUNITY; MINERAL SUPPLEMENTATION; NEUTROPHIL; POLARIZATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; VACCINATION; ZINC DEFICIENCY; ZINC HOMEOSTASIS; ZINC METABOLISM; BIOLOGICAL MODEL; DEFICIENCY; DIET SUPPLEMENTATION; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM;

AGING; DIETARY SUPPLEMENTS; HOMEOSTASIS; HUMANS; IMMUNITY; MODELS, BIOLOGICAL; ZINC;

EID: 84919678400     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.06.003     Document Type: Review

References (118)

1. Todd W., Elvelym A., Hart E. Zinc in the nutrition of the rat. Am J Physiol 1934, 107:146-156.
2. Prasad A.S., Miale A., Farid Z., Sandstead H.H., Schulert A.R. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. J Lab Clin Med 1963, 61:537-549.
3. Haase H., Rink L. Das essentielle spurenelement zink. Biologie unserer Zeit 2010, 40:314-321.
4. Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006, 20:3-18.
5. Haase H., Mocchegiani E., Rink L. Correlation between zinc status and immune function in the elderly. Biogerontology 2006, 7:421-428.
6. Kury S., Dreno B., Bezieau S., Giraudet S., Kharfi M., Kamoun R., et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002, 31:239-240.
7. Wang K., Zhou B., Kuo Y.M., Zemansky J., Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 2002, 71:66-73.
8. Neldner K.H., Hambidge K.M. Zinc therapy of acrodermatitis enteropathica. N Eng J Med 1975, 292:879-882.
9. Andreini C., Banci L., Bertini I., Rosato A. Counting the zinc-proteins encoded in the human genome. J Proteome Res 2006, 5:196-201.
10. Andreini C., Bertini I., Rosato A. Metalloproteomes: a bioinformatic approach. Acc Chem Res 2009, 42:1471-1479.
11. Rink L., Haase H. Zinc homeostasis and immunity. Trends Immunol 2007, 28:1-4.
12. Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006, 281:24085-24089.
13. Honscheid A., Rink L., Haase H. T-lymphocytes: a target for stimulatory and inhibitory effects of zinc ions. Endocr Metab Immune Disord Drug Targets 2009, 9:132-144.
14. Varin A., Larbi A., Dedoussis G.V., Kanoni S., Jajte J., Rink L., et al. In vitro and in vivo effects of zinc on cytokine signalling in human T cells. Exp Gerontol 2008, 43:472-482.
15. Capri M., Monti D., Salvioli S., Lescai F., Pierini M., Altilia S., et al. Complexity of anti-immunosenescence strategies in humans. Artif Organs 2006, 30:730-742.
16. Prasad A.S., Meftah S., Abdallah J., Kaplan J., Brewer G.J., Bach J.F., et al. Serum thymulin in human zinc deficiency. J Clin Invest 1988, 82:1202-1210.
17. Ibs K.H., Rink L. Zinc-altered immune function. J Nutr 2003, 133:1452s-1456s.
18. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., et al. T cells and aging, January 2002 update. Front Biosci 2002, 7:d1056-d1183.
19. Huang Y.P., Pechere J.C., Michel M., Gauthey L., Loreto M., Curran J.A., et al. In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. J Immunol 1992, 148:715-722.
20. Dubben S., Honscheid A., Winkler K., Rink L., Haase H. Cellular zinc homeostasis is a regulator in monocyte differentiation of HL-60 cells by 1 alpha, 25-dihydroxyvitamin D3. J Leukoc Biol 2010, 87:833-844.
21. Brieger A., Rink L., Haase H. Differential regulation of TLR-dependent MyD88 and TRIF signaling pathways by free zinc ions. J Immunol 2013, 191:1808-1817.
22. Fuchs T.A., Abed U., Goosmann C., Hurwitz R., Schulze I., Wahn V., et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007, 176:231-241.
23. Keshari R.S., Verma A., Barthwal M.K., Dikshit M. Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NETs release from human neutrophils. J Cell Biochem 2013, 114:532-540.
24. Hasan R., Rink L., Haase H. Zinc signals in neutrophil granulocytes are required for the formation of neutrophil extracellular traps. Innate Immun 2013, 19:253-264.
25. Keen C.L., Gershwin M.E. Zinc deficiency and immune function. Annu Rev Nutr 1990, 10:415-431.
26. Fraker P.J., King L.E. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 2004, 24:277-298.
27. Cakman I., Rohwer J., Schutz R.M., Kirchner H., Rink L. Dysregulation between TH1 and TH2T cell subpopulations in the elderly. Mech Ageing Dev 1996, 87:197-209.
28. Bonomini M., Di Paolo B., De Risio F., Niri L., Klinkmann H., Ivanovich P., et al. Effects of zinc supplementation in chronic haemodialysis patients. Nephrol Dial Transplant 1993, 8:1166-1168.
29. Weksler M.E., Szabo P. The effect of age on the B-cell repertoire. J Clin Immunol 2000, 20:240-249.
30. Howard W.A., Gibson K.L., Dunn-Walters D.K. Antibody quality in old age. Rejuvenation Res 2006, 9:117-125.
31. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009, 8:18-25.
32. Hijmans W., Radl J., Bottazzo G.F., Doniach D. Autoantibodies in highly aged humans. Mech Ageing Dev 1984, 26:83-89.
33. Silvestris F., Anderson W., Goodwin J.S., Williams R.C. Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 1985, 35:234-244.
34. Stacy S., Krolick K.A., Infante A.J., Kraig E. Immunological memory and late onset autoimmunity. Mech Ageing Dev 2002, 123:975-985.
35. Fraker P.J., King L.E., Laakko T., Vollmer T.L. The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000, 130:1399s-1406s.
36. DePasquale-Jardieu P., Fraker P.J. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr 1984, 114:1762-1769.
37. Sandstead H.H., Henriksen L.K., Greger J.L., Prasad A.S., Good R.A. Zinc nutriture in the elderly in relation to taste acuity, immune response, and wound healing. Am J Clin Nutr 1982, 36:1046-1059.
38. Fraker P.J., Gershwin M.E., Good R.A., Prasad A. Interrelationships between zinc and immune function. Fed Proc 1986, 45:1474-1479.
39. Rawer P., Willems W.R., Breidenbach T., Guttmann W., Pabst W., Schutterle G. Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation. Kidney Int Suppl 1987, 22:149-152.
40. Grekas D., Alivanis P., Kotzadamis N., Kiriazopoulou V., Pyrpasopoulos M., Tourkantonis A. Influenza vaccination in chronic hemodialysis patients. The effect of zinc supplementation. Ren Fail 1992, 14:575-578.
41. Brodersen H.P., Holtkamp W., Larbig D., Beckers B., Thiery J., Lautenschlager J., et al. Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study. Nephrol Dial Transplant 1995, 10:1780.
42. Provinciali M., Montenovo A., Di Stefano G., Colombo M., Daghetta L., Cairati M., et al. Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Ageing 1998, 27:715-722.
43. Duchateau J., Delepesse G., Vrijens R., Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med 1981, 70:1001-1004.
44. Cakman I., Kirchner H., Rink L. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 1997, 17:469-472.
45. Mocchegiani E., Veccia S., Ancarani F., Scalise G., Fabris N. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 1995, 17:719-727.
46. Porter K.G., McMaster D., Elmes M.E., Love A.H. Anaemia and low serum-copper during zinc therapy. Lancet 1977, 2:774.
47. Chandra R.K. Excessive intake of zinc impairs immune responses. JAMA 1984, 252:1443-1446.
48. Patterson W.P., Winkelmann M., Perry M.C. Zinc-induced copper deficiency: megamineral sideroblastic anemia. Ann Intern Med 1985, 103:385-386.
49. Reinhold D., Ansorge S., Grungreiff K. Immunobiology of zinc and zinc therapy. Immunol Today 1999, 20:102-103.
50. Wellinghausen N., Martin M., Rink L. Zinc inhibits interleukin-1-dependent T cell stimulation. Eur J Immunol 1997, 27:2529-2535.
51. Bao B., Prasad A., Beck F.W., Suneja A., Sarkar F. Toxic effect of zinc on NF-kappaB, IL-2, IL-2 receptor alpha, and TNF-alpha in HUT-78 (Th(0)) cells. Toxicol Lett 2006, 166:222-228.
52. Tanaka S., Akaishi E., Hosaka K., Okamura S., Kubohara Y. Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. Biochem Biophys Res Commun 2005, 335:162-167.
53. Hirano T., Matsuda T., Turner M., Miyasaka N., Buchan G., Tang B., et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988, 18:1797-1801.
54. Gruber K., Maywald M., Rosenkranz E., Haase H., Plumakers B., Rink L. Zinc deficiency adversely influences interleukin-4 and interleukin-6 signaling. J Biol Regul Homeost Agents 2013, 27:661-671.
55. Kopf M., Le Gros G., Bachmann M., Lamers M.C., Bluethmann H., Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993, 362:245-248.
56. Kahmann L., Uciechowski P., Warmuth S., Malavolta M., Mocchegiani E., Rink L. Effect of improved zinc status on T helper cell activation and TH1/TH2 ratio in healthy elderly individuals. Biogerontology 2006, 7:429-435.
57. Grossmann A., Rabinovitch P.S., Kavanagh T.J., Jinneman J.C., Gilliland L.K., Ledbetter J.A., et al. Activation of murine T-cells via phospholipase-C gamma 1-associated protein tyrosine phosphorylation is reduced with aging. J Gerontol 1995, 50:B205-B212.
58. Pahlavani M.A. T cell signaling: effect of age. Front Biosci 1998, 3:D1120-D1133.
59. Miller R.A., Garcia G., Kirk C.J., Witkowski J.M. Early activation defects in T lymphocytes from aged mice. Immunol Rev 1997, 160:79-90.
60. Kirk C.J., Miller R.A. Analysis of Raf-1 activation in response to TCR activation and costimulation in murine T-lymphocytes: effect of age. Cell Immunol 1998, 190:33-42.
61. Pahlavani M.A., Harris M.D., Richardson A. The age-related decline in the induction of IL-2 transcription is correlated to changes in the transcription factor NFAT. Cell Immunol 1995, 165:84-91.
62. Whisler R.L., Beiqing L., Chen M. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT. Cell Immunol 1996, 169:185-195.
63. Whisler R.L., Chen M., Beiqing L., Carle K.W. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging. Cell Immunol 1997, 175:41-50.
64. Trebilcock G.U., Ponnappan U. Evidence for lowered induction of nuclear factor kappa B in activated human T lymphocytes during aging. Gerontology 1996, 42:137-146.
65. + T cell subsets during aging. Mech Ageing Dev 1998, 102:149-163.
66. Herbein G., Varin A., Fulop T. NF-kappaB, AP-1, zinc-deficiency and aging. Biogerontology 2006, 7:409-419.
67. Fulop T., Larbi A., Douziech N., Levesque I., Varin A., Herbein G. Cytokine receptor signalling and aging. Mech Ageing Dev 2006, 127:526-537.
68. Daaboul D., Rosenkranz E., Uciechowski P., Rink L. Repletion of zinc in zinc-deficient cells strongly up-regulates IL-1beta-induced IL-2 production in T-cells. Metallomics 2012, 4:1088-1097.
69. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005, 205:158-169.
70. Weng N.P., Akbar A.N., Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 2009, 30:306-312.
71. Kaltenberg J., Plum L.M., Ober-Blobaum J.L., Honscheid A., Rink L., Haase H. Zinc signals promote IL-2-dependent proliferation of T cells. Eur J Immunol 2010, 40:1496-1503.
72. Prasad A.S. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 2000, 182(Suppl 1):S62-S68.
73. Cevenini E., Monti D., Franceschi C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care 2013, 16:14-20.
74. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 2002, 13:389-391.
75. Leng S.X., Yang H., Walston J.D. Decreased cell proliferation and altered cytokine production in frail older adults. Aging Clin Exp Res 2004, 16:249-252.
76. Chong M.S., Sahadevan S. Preclinical Alzheimer's disease: diagnosis and prediction of progression. Lancet Neurol 2005, 4:576-579.
77. Caruso C., Lio D., Cavallone L., Franceschi C. Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci 2004, 1028:1-13.
78. Wessels I., Haase H., Engelhardt G., Rink L., Uciechowski P. Zinc deficiency induces production of the proinflammatory cytokines IL-1beta and TNFalpha in promyeloid cells via epigenetic and redox-dependent mechanisms. J Nutr Biochem 2013, 24:289-297.
79. Rink L., Cakman I., Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998, 102:199-209.
80. Bao B., Prasad A.S., Beck F.W., Fitzgerald J.T., Snell D., Bao G.W., et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am j Clin Nutr 2010, 91:1634-1641.
81. Prasad A.S., Beck F.W., Bao B., Fitzgerald J.T., Snell D.C., Steinberg J.D., et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007, 85:837-844.
82. Heyninck K., Beyaert R. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett 1999, 442:147-150.
83. Lee E.G., Boone D.L., Chai S., Libby S.L., Chien M., Lodolce J.P., et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000, 289:2350-2354.
84. Klinkenberg M., Van Huffel S., Heyninck K., Beyaert R. Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions. FEBS Lett 2001, 498:93-97.
85. Opipari A.W., Boguski M.S., Dixit V.M. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 1990, 265:14705-14708.
86. Bao B., Prasad A.S., Beck F.W., Bao G.W., Singh T., Ali S., et al. Intracellular free zinc up-regulates IFN-gamma and T-bet essential for Th1 differentiation in Con-A stimulated HUT-78 cells. Biochem Biophys Res Commun 2011, 407:703-707.
87. Kahmann L., Uciechowski P., Warmuth S., Plumakers B., Gressner A.M., Malavolta M., et al. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 2008, 11:227-237.
88. Dowd P.S., Kelleher J., Guillou P.J. T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br J Nutr 1986, 55:59-69.
89. Mocchegiani E., Santarelli L., Muzzioli M., Fabris N. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Int J Immunopharmacol 1995, 17:703-718.
90. Simkin P.A. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976, 2:539-542.
91. Favier A., Favier M. Consequences des deficits en zinc durant la grossesse pour la mère et le nouveau-né (Consequences of zinc deficits during pregnancy for the mother and newborn). Revue Française de Gynecologie et d'Obstetrique 1990, 85:13-27.
92. Jameson S. Zinc status in pregnancy: the effect of zinc therapy on perinatal mortality, prematurity, and placental ablation. Ann N Y Acad Sci 1993, 678:178-192.
93. Bedwal R.S., Bahuguna A. Zinc, copper and selenium in reproduction. Experientia 1994, 50:626-640.
94. Danesh A., Janghorbani M., Mohammadi B. Effects of zinc supplementation during pregnancy on pregnancy outcome in women with history of preterm delivery: a double-blind randomized, placebo-controlled trial. J Matern Fetal Neonatal Med 2010, 23:403-408.
95. Stoye D., Schubert C., Goihl A., Guttek K., Reinhold A., Brocke S., et al. Zinc aspartate suppresses T cell activation in vitro and relapsing experimental autoimmune encephalomyelitis in SJL/J mice. Biometals 2012, 25:529-539.
96. Reding P., Duchateau J., Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 1984, 2:493-495.
97. Grungreiff K., Presser H.J., Franke D., Lossner B., Abicht K., Kleine F.D. Correlations between zinc, amino acids and ammonia in liver cirrhosis. Z Gastroenterol 1989, 27:731-735.
98. Takuma Y., Nouso K., Makino Y., Hayashi M., Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther 2010, 32:1080-1090.
99. Hennig B., Toborek M., McClain C.J. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr 2001, 20:97-105.
100. Salgueiro M.J., Krebs N., Zubillaga M.B., Weill R., Postaire E., Lysionek A.E., et al. Zinc and diabetes mellitus: is there a need of zinc supplementation in diabetes mellitus patients?. Biol Trace Elem Res 2001, 81:215-228.
101. Partida-Hernandez G., Arreola F., Fenton B., Cabeza M., Roman-Ramos R., Revilla-Monsalve M.C. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother 2006, 60:161-168.
102. Gunasekara P., Hettiarachchi M., Liyanage C., Lekamwasam S. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes 2011, 4:53-60.
103. Connell P., Young V.M., Toborek M., Cohen D.A., Barve S., McClain C.J., et al. Zinc attenuates tumor necrosis factor-mediated activation of transcription factors in endothelial cells. J Am Coll Nutr 1997, 16:411-417.
104. Prasad A.S., Bao B., Beck F.W., Kucuk O., Sarkar F.H. Antioxidant effect of zinc in humans. Free Radical Biol Med 2004, 37:1182-1190.
105. Yuasa K., Naganuma A., Sato K., Ikeda M., Kato N., Takagi H., et al. Zinc is a negative regulator of hepatitis C virus RNA replication. Liver Int 2006, 26:1111-1118.
106. Himoto T., Hosomi N., Nakai S., Deguchi A., Kinekawa F., Matsuki M., et al. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol 2007, 42:1078-1087.
107. Matsumura H., Nirei K., Nakamura H., Arakawa Y., Higuchi T., Hayashi J., et al. Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C. J Clin Biochem Nutr 2012, 51:178-184.
108. Bettger W.J., O'Dell B.L. A critical physiological role of zinc in the structure and function of biomembranes. Life Sci 1981, 28:1425-1438.
109. Shankar A.H., Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998, 68:447s-463s.
110. Karamyyar M., Gheibi S., Noroozi M., Kord Valeshabad A. Therapeutic effects of oral zinc supplementation on acute watery diarrhea with moderate dehydration: a double-blind randomized clinical trial. Iran J Med Sci 2013, 38:93-99.
111. Malik A., Taneja D.K., Devasenapathy N., Rajeshwari K. Short-course prophylactic zinc supplementation for diarrhea morbidity in infants of 6 to 11 months. Pediatrics 2013, 132:e46-e52.
112. Alam A.N., Sarker S.A., Wahed M.A., Khatun M., Rahaman M.M. Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. Gut 1994, 35:1707-1711.
113. Rahman M.J., Sarker P., Roy S.K., Ahmad S.M., Chisti J., Azim T., et al. Effects of zinc supplementation as adjunct therapy on the systemic immune responses in shigellosis. Am J Clin Nutr 2005, 81:495-502.
114. Raqib R., Roy S.K., Rahman M.J., Azim T., Ameer S.S., Chisti J., et al. Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis. Am J Clin Nut 2004, 79:444-450.
115. Roy S.K., Raqib R., Khatun W., Azim T., Chowdhury R., Fuchs G.J., et al. Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh. Eur J Clin Nutr 2008, 62:849-855.
116. Reiterer G., Toborek M., Hennig B. Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J Nutr 2004, 134:1711-1715.
117. Khan M.I., Siddique K.U., Ashfaq F., Ali W., Reddy H.D., Mishra A. Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients. J Nat Sci Bio Med 2013, 4:336-340.
118. Haase H., Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr 2009, 29:133-152.